Company: RGBP
Filing Date: 2025-05-13
Form Type: 8-K
Source: 0001641172-25-009967
Chunk: 1

Company: Regen BioPharma Inc
Filing Date: 2025-05-13
Form: 8-K
Item: Item 4.02
Chunk 1
---
034  
  NET INCOME (LOSS)                                              $                         (809,255      198,995      $              (668,255  

The
Company’s senior management has discussed the matters disclosed in this Item 4.02 of this Current Report with BCRG Group, the Company’s
independent registered public accounting firm.

SIGNATURE

Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.

                    REGEN BIOPHARMA, INC.                                            
  Dated:            By:                        /s/                                   
                                               David Koos                            
                                               Chairman and Chief Executive Officer